Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Sucampo launches RESCULA Eye Drops in the U.S.

Sucampo Pharmaceuticals, Inc. announced that RESCULA Eye Drops had been launched in the U.S. market.

21 Feb 2013

Ipsen, Inspiration Biopharmaceuticals sell IB1001 hemophilia B product to Cangene

Inspiration Biopharmaceuticals and Ipsen today announced the closing of the sale of the proprietary hemophilia B product, IB1001 (recombinant FIX), to Cangene Corporation.

20 Feb 2013

Oncolytics Biotech to commence underwritten public offering of common shares

Oncolytics Biotech Inc. announced today its intention, subject to market and other conditions, to commence an underwritten public offering of common shares. The number of common shares to be distributed and the price of each common share will be determined in the context of the market with final terms to be determined at the time of pricing.

19 Feb 2013

Otolaryngology, head and neck surgery: an interview with Thomas Cherry, Cook Medical

Cook Medical is the world’s largest privately held medical device manufacturer. The ENT division is Cook’s 10th business unit/clinical division and we are excited to meet the needs of ENT patients.

From COOK MEDICAL INC. 18 Feb 2013

Dietary impacts, health changes and oral pathogen genomic evolution

DNA preserved in calcified bacteria on the teeth of ancient human skeletons has shed light on the health consequences of the evolving diet and behaviour from the Stone Age to the modern day.

18 Feb 2013

U.S. Marshals seize tainted dietary supplements from Globe All Wellness

U.S. Marshals, acting on behalf of the U.S. Food and Drug Administration, today seized tainted dietary supplements from Globe All Wellness, LLC (Globe All), in Hollywood, Fla. The products may be unsafe because they contain an undisclosed active pharmaceutical ingredient.

15 Feb 2013

IOM proposes state, FDA actions to stop growth of counterfeit drugs

The Institute of Medicine Wednesday urged a series regulatory changes to help protect the public against buying fake or poorly made drugs.

15 Feb 2013

Viewpoints: FDA needs more power to regulate compounding pharmacies; Time to revamp military benefits, including health

Traditionally, the licensing and control of pharmacies has been left to the states, but their performance has been uneven. The federal role has been thrown into question in recent years by lawsuits. ... compounding pharmacies are not generally required to inform the FDA that they are in business nor to register with the FDA or disclose what products they are making.

15 Feb 2013

Cambrex, Dow partner to manufacture HPMCAS for drug solubility enhancement

Cambrex and The Dow Chemical Company have executed an agreement for Cambrex to contract manufacture Dow Hydroxypropyl Methylcellulose Acetate Succinate (HPMCAS) for Drug Solubility Enhancement.

15 Feb 2013

Roundup: States get insurance exchange weapon on abortion; N.Y. budget woes include Medicaid money worry; Ga. hospital 'bed tax' might not offer budget solution

Abortion opponents have found a new way to restrict access to abortion -- by using the authority states have over the new health insurance exchanges, which will be up and running in a year. At least 21 states have legislation in place or in the works that will stop health insurance companies from paying for abortions for women.

15 Feb 2013

Tianyin Pharmaceutical second quarter revenue decreases 3.3% to $17.6 million

Tianyin Pharmaceutical Inc., a pharmaceutical company that specializes in the patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) announced financial results for second quarter of the fiscal year 2013.

14 Feb 2013

New paper advances scientific understanding of glycoproteins’ structure and function

A Simon Fraser University chemist is the lead author on a new paper that advances scientific understanding of the structure and function of glycoproteins, in particular the number and positioning of sugars on them.

14 Feb 2013

Dyax fourth quarter total revenues increase to $16.0 million

Dyax Corp. today announced financial results for the fourth quarter and year ended December 31, 2012.

14 Feb 2013

LSR grades for medical device manufacturers and fabricators debuted by Dow Corning at MD&M West

Dow Corning, a global leader in silicones, silicon-based technology and innovation for the healthcare industry, is showcasing at MD&M West (Hall D, Booth# 1751) Dow Corning® QP1 liquid silicone rubber (LSR) grades that give medical device manufacturers and fabricators broader material choices for intricate devices and components.

13 Feb 2013

Landauer reports revenue of $36.7 million for first quarter 2013

Landauer, Inc., a recognized leader in personal and environmental radiation measurement and monitoring, outsourced medical physics services and high quality medical consumable accessories, today reported financial results for its fiscal 2013 first quarter ended December 31, 2012.

11 Feb 2013

Decade Sunshine, 3SBio enter Merger Agreement

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced that it has entered into an agreement and plan of merger with Decade Sunshine Limited, an exempted company with limited liability incorporated under the laws of the Cayman Islands, and Decade Sunshine Merger Sub, an exempted company with limited liability incorporated under the laws of the Cayman Islands and a direct wholly owned subsidiary of Parent.

10 Feb 2013

Lannett second quarter net sales increase 32% to $36.6 million

Lannett Company, Inc. today reported continued strong momentum, with sharply improved financial results for its fiscal 2013 second quarter ended December 31, 2012, compared with the prior year period.

7 Feb 2013

Sangamo BioSciences fourth quarter revenues increase to $8.9 million

Sangamo BioSciences, Inc. today reported fourth quarter and full year 2012 financial results and accomplishments.

7 Feb 2013

Viracor-IBT Laboratories signs definitive agreement to purchase assets of Cylex

Viracor-IBT Laboratories, Inc. announced today that it has signed a definitive agreement to purchase the assets of Cylex, Inc., a global life sciences company focused on the development, manufacturing and commercialization of in vitro diagnostic products intended to illuminate immunity in the area of transplant medicine.

5 Feb 2013

Injection-free vaccination technique shows promise

Study findings show that a new injection-free vaccination technique, applied through a patch on the skin, can induce the same level of immune response as a standard vaccine injection when given to mice.

5 Feb 2013

Manufacturing News and Research

Further Reading

Sucampo launches RESCULA Eye Drops in the U.S.

Ipsen, Inspiration Biopharmaceuticals sell IB1001 hemophilia B product to Cangene

Oncolytics Biotech to commence underwritten public offering of common shares

Otolaryngology, head and neck surgery: an interview with Thomas Cherry, Cook Medical

Dietary impacts, health changes and oral pathogen genomic evolution

U.S. Marshals seize tainted dietary supplements from Globe All Wellness

IOM proposes state, FDA actions to stop growth of counterfeit drugs

Viewpoints: FDA needs more power to regulate compounding pharmacies; Time to revamp military benefits, including health

Cambrex, Dow partner to manufacture HPMCAS for drug solubility enhancement

Roundup: States get insurance exchange weapon on abortion; N.Y. budget woes include Medicaid money worry; Ga. hospital 'bed tax' might not offer budget solution

Tianyin Pharmaceutical second quarter revenue decreases 3.3% to $17.6 million

New paper advances scientific understanding of glycoproteins’ structure and function

Dyax fourth quarter total revenues increase to $16.0 million

LSR grades for medical device manufacturers and fabricators debuted by Dow Corning at MD&M West

Landauer reports revenue of $36.7 million for first quarter 2013

Decade Sunshine, 3SBio enter Merger Agreement

Lannett second quarter net sales increase 32% to $36.6 million

Sangamo BioSciences fourth quarter revenues increase to $8.9 million

Viracor-IBT Laboratories signs definitive agreement to purchase assets of Cylex

Injection-free vaccination technique shows promise

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest Life Science News